|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2001;122:849-850
© 2001 The American Association for Thoracic Surgery
Editorials |
From the Department of Surgery, University of Minnesota, Minneapolis, Minn.
Received for publication Aug 8, 2001. Accepted for publication Sept 13, 2001. Address for reprints: Michael Maddaus, MD, Department of Surgery, University of Minnesota, 420 Delaware St, Box 207, Minneapolis, MN 55455.

See related article on page 891.
If in doubt, give the patient the benefit of the doubt." Dr Robert Ginsberg taught me this while I trained with him in the early 1990s at Memorial Sloan-Kettering Cancer Center. Since that moment, I have adhered to this principle, with frequent significant benefit to my patients.
Noninvasive radiologic preoperative staging of nonsmall cell lung cancer (NSCLC) has dramatically changed over the past decade. High-resolution spiral computed tomography (CT) can now delineate nearly all enlarged hilar and mediastinal lymph nodes and can detect other lung nodules as small as 1.0 mm. Positron emission tomography (PET) scanning now provides a whole-body image search for metastases. Whether CT or PET is used, a problem arises when a result is equivocal or uncertain. With PET scanning, the answer to a negative result may be easyoperate. A positive
Related Article
J. Thorac. Cardiovasc. Surg. 2001 122: 891-899.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |